Physician profile
Kaley Hudson
NPI 1154043388
$1,499.42
in general payments reported to CMS, 2019-2025
20 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.66 · 2023: $619 · 2024: $418 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $276.07 | 2023-2025 | Wegovy, Ozempic |
| Astellas Pharma US INC | $153.02 | 2024-2025 | Veozah |
| Lilly USA, LLC | $137.29 | 2024-2025 | Zepbound |
| Exeltis, USA INC. | $122.60 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $106.87 | 2022-2023 | |
| Abbvie INC. | $81.97 | 2023-2025 | |
| Aspira Women'S Health INC | $79.92 | 2023 | Ova1 |
| Exact Sciences Corporation | $76.66 | 2024-2025 | Cologuard Collection Kit |
| Organon LLC | $74.10 | 2022-2024 | Nexplanon |
| Evofem Biosciences, INC. | $74.00 | 2024-2025 | Solosec, Phexx, Phexxi |
| Sumitomo Pharma America, INC. | $64.60 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $56.84 | 2023-2025 | Aptima, Novasure |
| Currax Pharmaceuticals LLC | $47.50 | 2023 | Onzetra Xsail, Contrave |
| Mayne Pharma Commercial LLC | $32.46 | 2023-2024 | |
| Daiichi Sankyo INC. | $28.38 | 2023 | Injectafer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $23.68 | 2025 | Femlyv |
| Convatec INC. | $21.81 | 2023 | |
| Pfizer INC. | $15.59 | 2024 | |
| Coopersurgical, INC. | $13.59 | 2025 | |
| Agile Therapeutics, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaley Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.